Driving Investment and Innovation in Life Sciences
Join Deloitte at 2022 Financial Times Global Pharma and Biotech Summit, an industry-leading conference which brings together the world’s biggest pharma companies and other major organisations across the life sciences and health care value chain. The annual event is essential for you to stay on top of the latest trends and innovations in life sciences. CEOs, policymakers and thought leaders from around the world will explore new frontiers for business and for health care and discuss what’s new in areas such as drug discovery, clinical trials and market access.
While the life sciences and health care industry is witnessing a technological innovation since the pandemic, how is the competition between pharma companies and institutional investors for biotech platforms evolving? The industry is already transforming the clinical trial landscape and leveraging health care intelligence, but is scientific complexity still a hurdle? At the same time, the role of companies’ ethics, sustainability and customer value factors could be at the heart of any responsible business strategy. Deloitte leaders, along with industry peers, will unpack many of these critical questions and more at this year’s conference.
Deloitte is proud to once again be a lead sponsor and is pleased to offer a discounted registration to this year’s conference.
Register now to receive a 25% discount
Conference themes:
- Showing Leadership: What does a good workforce transformation strategy look like? How do pharma companies set ESG goals? How do CEOs make the big calls on where to focus investment?
- Supporting Innovation: Will cross-industry collaboration continue beyond the pandemic? How is technology transforming R&D? What are the latest next-generation therapies?
- Saving Lives: What does the rise of precision medicine look like? How can pharma companies become more patient-centric? How can high-cost treatments be made more accessible and affordable?
